Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology
Which Tumor Marker Can Be Used to Assess Stage, Prognosis, Response to Treatment? | ONS Voice
Liquid biomarkers in melanoma: detection and discovery | Molecular Cancer | Full Text
Biomarkers in Malignant Melanoma: Recent Trends and Critical Perspective - Cutaneous Melanoma - NCBI Bookshelf
Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy.
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance - ScienceDirect
Cancers | Free Full-Text | Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
Melanoma | Encyclopedia MDPI
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy | PNAS
SciELO - Brasil - Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma
Frontiers | Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects
Melanoma (malignant melanoma)
Standard melanoma-associated markers do not identify the MM127 metastatic melanoma cell line | Scientific Reports
Clinicopathological features, tumor markers, HMGA1, and uveal melanoma... | Download Table
A Seven-Marker Signature and Clinical Outcome in Malignant Melanoma: A Large-Scale Tissue-Microarray Study with Two Independent Patient Cohorts | PLOS ONE
A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma | Modern Pathology
How to Detect Skin Cancer | Roswell Park Comprehensive Cancer Center - Buffalo, NY
Frontiers | Evaluating Biomarkers in Melanoma
Melanoma Markers | GeneTex
-Antibody-(A103-+-T311-+-HMB45)-Flow-(Intracellular)-NBP2-34339-img0003.jpg "Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (A103 + T311 + HMB45) (NBP2-34339): Novus Biologicals")
Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (A103 + T311 + HMB45) (NBP2-34339): Novus Biologicals
Frontiers | Current Trends in Circulating Biomarkers for Melanoma Detection
Skin Cancer: New Markers for Better Prevention | Semantic Scholar
Serologic Markers of Malignant Melanoma | Download Table
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms - eBioMedicine
